According to reports from Business Standard, Shree Ram Proteins reported a standalone net loss of ₹6.36 crore in the quarter ended June 2026, representing a significant deterioration from the net loss of ₹1.82 crore recorded during the corresponding quarter of the previous financial year. The company's financial performance shows a substantial increase in losses year-over-year, indicating operational challenges during the first quarter of FY27.
As reported by Business Standard, the company reported nil sales for both the quarter ended June 2026 and the corresponding quarter of the previous financial year. This absence of revenue generation across both periods highlights the company's operational challenges and potential business model restructuring efforts during the quarter.
According to the financial data reported by Business Standard, the net loss of ₹6.36 crore in Q1 FY27 represents a threefold increase compared to the net loss of ₹1.82 crore recorded in the same quarter of the previous financial year. This substantial increase in losses indicates either increased operational expenses or reduced revenue generation capabilities during the quarter.
Recent market data reveals significant volatility in Shree Ram Proteins stock performance, with the stock experiencing a maximum positive change of 33.33% in August 2020, though it has also seen substantial declines including a maximum negative change of 37.93% in August 2023. The stock's average performance shows average positive changes of 13.76% and average negative changes of -13.85%, indicating the company's stock has been subject to significant market fluctuations over the past few years.
